PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PDAC - PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy targets Hard-to-Treat cancers
Disease control TEMPORARILY_NOT_AVAILABLEThis treatment program is for people with advanced pancreatic or colorectal cancer that has a specific genetic change called KRAS G12D. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack the cancer, and then give them back. The goal is …
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Can digestive enzymes help pancreatic cancer patients keep weight on?
Disease control OngoingThis study looks at whether taking pancreatic enzymes (pancrelipase) can help people with advanced pancreatic cancer maintain or gain weight. The trial enrolled 17 participants who are receiving standard chemotherapy. Researchers will measure changes in body mass index over 4 mon…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New hope for pancreatic cancer: targeted drug enters final testing phase
Disease control OngoingThis phase 3 trial tests a new drug called daraxonrasib (RMC-6236) against standard treatments for people with metastatic pancreatic cancer that has already been treated. About 500 adults with a specific RAS gene mutation will be randomly assigned to receive either the new drug o…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New MRI technique may forecast pancreatic cancer outcomes
Knowledge-focused TerminatedThis study explores whether a new type of MRI (6D-MRI) can predict how well pancreatic cancer patients respond to treatment. Researchers will scan 36 patients before and during chemotherapy to see if imaging features can forecast cancer progression or successful surgery. The stud…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:26 UTC